Literature DB >> 26407946

Molecular evidence of insulinomimetic property exhibited by steviol and stevioside in diabetes induced L6 and 3T3L1 cells.

Salini Bhasker1, Harish Madhav1, Mohankumar Chinnamma2.   

Abstract

BACKGROUND: The defective responsiveness of body tissues to insulin involves the insulin receptors of cell membranes. The binding of insulin to its receptor induce an increase of high affinity glucose transporter molecules in target cell surface that enhance the uptake of glucose in to these cells. The WHO expert committee recommended the importance to investigate the hypoglycemic agents from plant origin, which are used in traditional medicine for the treatment of diabetes. Stevioside, a natural sweetener and a diterpene glycoside extracted from Stevia rebaudiana (Bertoni) has been used as an anti-hyperglycemic agent for the treatment of diabetes for decades. HYPOTHESIS: To reveal the molecular mechanism underlying the insulinomimetic activity of stevioside and its aglycone metabolite, steviol using cell line models. STUDY
DESIGN: Efficacy of stevioside and steviol in inducing glucose absorption was studied at transcript level, protein level and by measuring glucose absorption in the cell using in-vitro cell line studies.
METHOD: Quantification of glucose transporter (GLUT4) transcript was done in 3T3-L1 adipocytes and L6 myotubes by qPCR using RPL23 as the internal control. GLUT4 protein was quantified using anti GLUT4 antibody by ELISA and radioactive glucose uptake studies were done to measure the rate of glucose absorption.
RESULTS: The absolute and relative quantitation of GLUT4 gene by qPCR showed the activation of GLUT4 transcript at lower concentration of steviol (1 µM) and higher concentration of stevioside (100 µM) in both L6 myotubes and 3T3-L1 adipocytes. The increased level of glut4 protein and the glucose uptake in both the cell lines using the same concentration of steviol and stevioside further supports the qPCR data. The copy number and the expression level of GLUT4 gene, the amount of GLUT4 protein and the glucose uptake efficacy support the insulinomimetic effect of steviol and stevioside.
CONCLUSION: The results of the study clearly demonstrate the functional similarity of steviol and stevioside with that of insulin in controlling the level of glucose in both the cell lines. In other words, the insulinomimetic property of stevioside and steviol was evident from the data.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  3T3-L1; Glucose transporter; Insulinomimetic; L6; Steviol; Stevioside

Mesh:

Substances:

Year:  2015        PMID: 26407946     DOI: 10.1016/j.phymed.2015.07.007

Source DB:  PubMed          Journal:  Phytomedicine        ISSN: 0944-7113            Impact factor:   5.340


  5 in total

1.  Glycosides from Stevia rebaudiana Bertoni Possess Insulin-Mimetic and Antioxidant Activities in Rat Cardiac Fibroblasts.

Authors:  Cecilia Prata; Laura Zambonin; Benedetta Rizzo; Tullia Maraldi; Cristina Angeloni; Francesco Vieceli Dalla Sega; Diana Fiorentini; Silvana Hrelia
Journal:  Oxid Med Cell Longev       Date:  2017-08-30       Impact factor: 6.543

Review 2.  Current understanding of glucose transporter 4 expression and functional mechanisms.

Authors:  Tiannan Wang; Jing Wang; Xinge Hu; Xian-Ju Huang; Guo-Xun Chen
Journal:  World J Biol Chem       Date:  2020-11-27

3.  Synthesis and Biological Application of Isosteviol-Based 1,3-Aminoalcohols.

Authors:  Dániel Ozsvár; Viktória Nagy; István Zupkó; Zsolt Szakonyi
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

Review 4.  Effect of stevia leaves (Stevia rebaudiana Bertoni) on diabetes: A systematic review and meta-analysis of preclinical studies.

Authors:  Akibul Islam Chowdhury; Mohammad Rahanur Alam; M Maruf Raihan; Tanjina Rahman; Saiful Islam; Oumma Halima
Journal:  Food Sci Nutr       Date:  2022-04-24       Impact factor: 3.553

Review 5.  Natural Products to Counteract the Epidemic of Cardiovascular and Metabolic Disorders.

Authors:  Birgit Waltenberger; Andrei Mocan; Karel Šmejkal; Elke H Heiss; Atanas G Atanasov
Journal:  Molecules       Date:  2016-06-22       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.